NCT03789409 is a NA clinical trial of Intermittent Fasting in Ischemic Stroke, sponsored by Ulsan University Hospital.

Who is sponsoring NCT03789409?

NCT03789409 is sponsored by Ulsan University Hospital.

What drugs are being tested in NCT03789409?

Interventions in NCT03789409: Intermittent Fasting.

What condition does NCT03789409 study?

NCT03789409 studies Ischemic Stroke, Intermittent Fasting.

Is NCT03789409 still recruiting?

NCT03789409 is currently status unknown. Last updated 17 December 2019.

Last reviewed 2019-12-17 · How we verify

NCT03789409

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intermittent Fasting Following Acute Ischemic Stroke

Status unknown NA Last updated 17 December 2019

What this trial tests

NA trial testing Intermittent Fasting in Ischemic Stroke in 68 participants. Status unknown.

Timeline

4 March 2019

Primary endpoint
31 January 2021

31 January 2021

Quick facts

Lead sponsor	Ulsan University Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	68
Start date	4 March 2019
Primary completion	31 January 2021
Estimated completion	31 January 2021
Sites	1 location across South Korea

Drugs / interventions tested

Intermittent Fasting

Conditions studied

Ischemic Stroke — all drugs for Ischemic Stroke →
Intermittent Fasting — all drugs for Intermittent Fasting →

Sponsor

Ulsan University Hospital

Who can join

20 and older, any sex, with Ischemic Stroke or Intermittent Fasting. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Despite numerous kinds of evidence on functional health and CNS protection of intermittent fasting after injuries were found in many brain-, and spinal cord-damaged animal models, there has yet to be any clinical study of intermittent fasting after acute ischemic cerebral infarction. The aim of this study is to evaluate the neurological, functional and clinical efficacy of intermittent fasting in patients after acute ischemic stroke.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Intermittent fasting for the prevention of cardiovascular disease.
Allaf M, Elghazaly H, Mohamed OG, Fareen MFK, et al · · 2021 · cited 66× · PMID 33512717 · DOI 10.1002/14651858.cd013496.pub2

Verify or expand the search:

Other trials of Intermittent Fasting

Trials testing the same drug.

NCT06615817 — Intermittent Fasting, Mediterranean Diet and NAFLD · NA · not yet recruiting
NCT06106477 — Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for · NA · recruiting
NCT06386887 — Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer · NA · recruiting
NCT06766747 — Efficacy of Intermittent Fasting Versus Continuous Caloric Restriction in the Treatment of Significant Weight Regain Aft · NA · completed
NCT06172283 — Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy · NA · recruiting

Other recruiting trials for Ischemic Stroke

Currently open trials in the same condition.

NCT07509645 — Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Post · Phase 3 · recruiting
NCT07375953 — Repeated Intravenous Thrombolysis for Ischemic Stroke Within 3.0 Hours of Onset With Tenecteplase (RITIS-TNK) · Phase 2 · recruiting
NCT07375966 — Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours · Phase 2 · recruiting
NCT07491952 — Continuous Dual Aspiration Technique With Zoom System for Stroke · recruiting
NCT07371455 — A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LWP779 in Healthy Participants · Phase 1 · recruiting

Other Ulsan University Hospital trials

Trials by the same sponsor.

NCT07398001 — Discontinuation of Antiplatelet Therapy After Drug-Coated Balloon Treatment · NA · not yet recruiting
NCT07057648 — Shape-Sensing Robotic-Assisted Bronchoscopy for Diagnosis of Peripheral Pulmonary Nodules in Korea · recruiting
NCT03270852 — Enhanced Reality for Hemiparetic Arm in the Stroke Patients · NA · unknown
NCT03787524 — Prediction of Functional Health Status and Aspiration Using Multiple Dysphagia Scales Over 6 Months After Acute Stroke · unknown
NCT03779815 — Detection of Amyloidosis in Multiple Myeloma Patients by [18F]Florbetaben Positron Emission Tomography · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03789409 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ulsan University Hospital
Last refreshed: 17 December 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03789409.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing